Amarillo TX 心力衰竭临床试验
8项针对 心力衰竭的研究正在 Amarillo及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
招募中3 期
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
招募中3 期
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- PharmaTex Research, LLC, Amarillo
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
招募中3 期
- Research Site, Amarillo
- Research Site, Amarillo
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
招募中2 期
- Amarillo Medical Specialists, Amarillo
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
招募中3 期
- CON-10045 Amarillo, TX Investigational Site, Amarillo
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Amarillo, TX Investigative Site 10045, Amarillo
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- PharmaTex Research, LLC, Amarillo
其他城市的 心力衰竭试验
- New York City, NY51 项研究
- Boston, MA46 项研究
- Dallas, TX42 项研究
- Houston, TX35 项研究
- Cleveland, OH31 项研究
- Philadelphia, PA31 项研究
- San Francisco, CA29 项研究
- Chicago, IL28 项研究
- Durham, NC25 项研究
- Kansas City, MO25 项研究
- St. Louis, MO24 项研究
- Indianapolis, IN24 项研究
Amarillo的其他研究
- 非小细胞肺癌9 项研究
- 肥胖症7 项研究
- 肺癌5 项研究
- 超重4 项研究
- 心血管疾病4 项研究
- 血栓4 项研究
- 乳腺癌4 项研究
- 冠状动脉疾病3 项研究
- 结直肠癌3 项研究
- 心房颤动3 项研究
- 消化系统疾病3 项研究
- 动脉粥样硬化3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。